@NPR — A Single Bimonthly Injection Of #Cabotegravir Proven Effective In Protecting Women Against #HIV

(NPR) — A new HIV prevention technique has proven remarkably effective at protecting women against the virus.

A new study finds a single injection of a drug called cabotegravir given every two months was more effective than a daily oral dose of Truvada.
.

A single injection of a drug called cabotegravir given every two months has been shown to be more effective than a daily oral dose of Truvada.

A single injection of a drug called cabotegravir every two months was so successful in preventing HIV in a clinical trial among women in sub-Saharan Africa that the study was wrapped up ahead of schedule.

The study, run by the HIV Prevention Trials Network, was looking at two forms of pre-exposure prophylaxis or (PrEP) aimed at women. PrEP is a technique of administering low doses of anti-AIDS drugs to people who are HIV negative as a way to protect them from infection. The study compared the effectiveness of the new long-acting injectable against the current form of PrEP, a daily pill of Truvada.

The findings were announced by the study's researchers on Monday.

Source: NPR, full story

 

Leave a Reply